mRS = 0 to 4 (N = 1025) | mRS ≥ 5 (N = 116) | Test statistics | |
---|---|---|---|
Age | 73.2 ± 13.4 | 83.1 ± 8.4 | U = 86,889.000, Z = 8.160, p < 0.001c |
Sex-female | 460/1025 (44.9%) | 67/116 (57.8%) | 6.956/0.008a |
Aetiology of stroke | |||
LAAS | 145 (14.2%) | 21 (18.9%) | 31.765/< 0.001a |
CES | 262 (25.6%) | 52 (46.8%) | |
SVD | 229 (22.4%) | 9 (8.1%) | |
Other | 4 (0.4%) | 0 (0%) | |
Cryptogenic stroke | 204 (19.9%) | 17 (15.3%) | |
ESUS | 179 (17.5%) | 12 (10.8%) | |
Event to door time | |||
≤ 2 h | 574/1025 (56.0%) | 53/116 (45.7%) | 4.475/0.034a |
Door to needle time | 46.7 ± 27.1 min | 51.4 ± 32.4 min | U = 63,468.500, Z = 1.409, p = 0.159c |
(Median 40) | (Median 42) | ||
Severity indices on admission | |||
Modified Rankin Scale on admission | 3.1 ± 0.9 | 4.3 ± 0.9 | U = 96,140.000, Z = 11.496, p < 0.001c |
Median: 3 | Median: 5 | ||
Modified Rankin Scale on admission | Score 0: 4 (0.4%) | Score 0: 0 (0%) | 190.277/< 0.001a |
Score 1: 18 (1.8%) | Score 1: 0 (0%) | ||
Score 2: 257 (25.1%) | Score 2: 4 (3.4%) | ||
Score 3: 456 (44.5%) | Score 3: 20 (17.2%) | ||
Score 4: 198 (19.3%) | Score 4: 32 (27.6%) | ||
Score 5: 91 (8.9%) | Score 5: 60 (51.7%) | ||
NIHSS on admission | 6.3 ± 4.8 | 13.9 ± 7.6 | U = 97,796.000, Z = 11.476, p < 0.001c |
Median: 5 | Median: 14 | ||
NIHSS after 24 h | 3.6 ± 4.2 | 16.3 ± 8.1 | U = 83,353.000, Z = 13.521, p < 0.001c |
Median: 2 | Median: 16 | ||
Risk factors | |||
Hypertension | 921/1025 (89.9%) | 112/116 (96.6%) | 5.456/0.020a |
Systolic blood pressure on admission | 164.4 ± 27.2 mm Hg | 163.8 ± 30.5 mm Hg | U = 54,982.000, Z = 0.299, p = 0.765c |
Diastolic blood pressure on admission | 89.2 ± 15.7 mm Hg | 88.4 ± 19.5 mm Hg | U = 52,006.000, Z = 1.224, p = 0.221c |
Diabetes mellitus | 245/1025 (23.9%) | 28/116 (24.1%) | 0.003/0.955a |
Blood glucose level on admission | 135.8 ± 47.4 mg/dl | 156.4 ± 82.6 mg/dl | U = 67,353.500, Z = 2.369, p = 0.018c |
HbA1c | 42.6 ± 12.2 mmol/mol | 44.2 ± 14.6 mmol/mol | U = 54,029.000, Z = 0.160, p = 0.873c |
Cholesterol level on admission | 198.5 ± 49.7 mg/dl | 192.6 ± 55.4 mg/dl | U = 50,652.500, Z = 1.386, p = 0.166c |
LDL level on admission | 126.2 ± 43.2 mg/dl | 125.0 ± 44.9 mg/dl | U = 52,609.000, Z = 0.400, p = 0.689c |
Statine therapy on admission | 313/1020 (30.7%) | 29/114 (25.4%) | 1.341/0.247a |
CRP level on admission | 7.6 ± 19.3 mg/dl | 21.3 ± 42.9 mg/dl | U = 77,073.500, Z = 5.262, p < 0.001c |
Atrial fibrillation | 210/1025 (20.5%) | 49/116 (42.2%) | 28.103/< 0.001a |
Former stroke | 242/1025 (23.6%) | 33/116 (28.4%) | 1.334/0.248a |
Antiaggregant therapy on admission | 406/1017 (39.9%) | 50/115 (43.5%) | 0.543/0.461a |
Complications | |||
Intracerebral bleeding | 59/1025 (5.8%) | 23/115 (20.0.%) | 36.484/< 0.001a |
Seizure | 14/1025 (1.4%) | 9/116 (7.8%) | 21.561/< 0.001a |
Recurrent stroke/TIA within 72 h | 2/1025 (0.2%) | 1/116 (0.9%) | 1.768/0.184a |
Infection within 72 h | 202/1025 (19.7%) | 68/116 (58.6%) | 87.354/< 0.001a |
Delirium | 63/1025 (6.1%) | 10/116 (8.6%) | 1.065/0.302a |
Pre-stroke living situation | |||
German level of care (0–5) | 0: 400 (85.1%) | 0: 6 (50.0%) | 17.571/0.001a |
1: 7 (1.5%) | 1: 0 (0%) | ||
2: 37 (7.9%) | 2: 2 (16.7%) | ||
3: 19 (4.0%) | 3: 3 (25.0%) | ||
4: 7 (1.5%) | 4: 1 (8.3%) | ||
5: 0 (0%) | 5: 0 (0%) |